Literature DB >> 15921959

RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysis.

Miran Javorovic1, Heike Pohla, Bernhard Frankenberger, Thomas Wölfel, Dolores J Schendel.   

Abstract

Previous studies have analyzed transfer of RNA-encoded tumor-associated antigens (TAAs) into immature dendritic cells (DCs) because of their exceptional ability to internalize antigens. Concerns have been raised regarding the use of immature DCs in clinical studies because of their capacity to tolerize T cells. Therefore, we focused on optimizing RNA transfer into mature DCs using the method of electroporation and obtained high protein expression in 90% of mature DCs. Particular emphasis was placed on quantifying RNA transfer. Reconstitution of peptide-MHC (pMHC) ligands on RNA-pulsed DCs was measured with the help of effector-memory cytotoxic T lymphocytes (CTLs) specific for the melanoma-associated antigens tyrosinase and mutated cyclin-dependent kinase 4. In contrast to single-species RNA, transfer of native tumor-derived RNA or amplified tumor RNA into DCs resulted in very low or no capacity to reactivate these CTLs. A correlation was found between TAA message levels in tumor-derived RNA and pMHC ligand reconstitution on DCs. These results demonstrate that even TAAs with highly immunogenic mutated epitopes are not necessarily transferred when tumor-derived RNA is transfected into the DCs, thereby resulting in a lack of DC capacity to reactivate some preexisting effector-memory CTLs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921959     DOI: 10.1016/j.ymthe.2005.03.034

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  12 in total

1.  A generic RNA pulsed DC based approach for developing therapeutic intervention against nasopharyngeal carcinoma.

Authors:  Rajeev K Tyagi; Rajesh Parmar; Naisargee Patel
Journal:  Hum Vaccin Immunother       Date:  2016-11-30       Impact factor: 3.452

2.  Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.

Authors:  Alexandra G Orlandini von Niessen; Marco A Poleganov; Corina Rechner; Arianne Plaschke; Lena M Kranz; Stephanie Fesser; Mustafa Diken; Martin Löwer; Britta Vallazza; Tim Beissert; Valesca Bukur; Andreas N Kuhn; Özlem Türeci; Ugur Sahin
Journal:  Mol Ther       Date:  2018-12-18       Impact factor: 11.454

Review 3.  Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.

Authors:  Bernhard Frankenberger; Sybille Regn; Christiane Geiger; Elfriede Noessner; Christine S Falk; Heike Pohla; Miran Javorovic; Tobias Silberzahn; Susanne Wilde; Alexander Buchner; Michael Siebels; Ralph Oberneder; Gerald Willimsky; Antonio Pezzutto; Thomas Blankenstein; Dolores J Schendel
Journal:  World J Urol       Date:  2005-07-05       Impact factor: 4.226

4.  Transfection by Electroporation of Cancer and Primary Cells Using Nanosecond and Microsecond Electric Fields.

Authors:  Eivina Radzevičiūtė; Veronika Malyško-Ptašinskė; Jurij Novickij; Vitalij Novickij; Irutė Girkontaitė
Journal:  Pharmaceutics       Date:  2022-06-11       Impact factor: 6.525

5.  High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA.

Authors:  Nada M Melhem; Sherrianne M Gleason; Xiang Dong Liu; Simon M Barratt-Boyes
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

6.  Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation.

Authors:  Maja Bürdek; Stefani Spranger; Susanne Wilde; Bernhard Frankenberger; Dolores J Schendel; Christiane Geiger
Journal:  J Transl Med       Date:  2010-09-28       Impact factor: 5.531

Review 7.  Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.

Authors:  Christiane Geiger; Elfriede Nössner; Bernhard Frankenberger; Christine S Falk; Heike Pohla; Dolores J Schendel
Journal:  J Mol Med (Berl)       Date:  2009-03-07       Impact factor: 4.599

8.  Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells: A three phase experimental procedure.

Authors:  Susanne Wilde; Christiane Geiger; Slavoljub Milosevic; Barbara Mosetter; Sabine Eichenlaub; Dolores J Schendel
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

9.  A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma.

Authors:  Christiane Geiger; Sybille Regn; Andreas Weinzierl; Elfriede Noessner; Dolores J Schendel
Journal:  J Transl Med       Date:  2005-07-26       Impact factor: 5.531

10.  Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.

Authors:  Anke Zobywalski; Miran Javorovic; Bernhard Frankenberger; Heike Pohla; Elisabeth Kremmer; Iris Bigalke; Dolores J Schendel
Journal:  J Transl Med       Date:  2007-04-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.